Two banking stocks to watch ahead of the RBI Policy

By Kiran Jani

Bank Nifty reached its all-time high of 54,467 in September 2024. Following this peak, the index experienced a correction, dipping to 47,844 in January 2025—a decline of 7.29%. Despite this pullback, Kotak Bank and ICICI Bank showed relative resilience, delivering returns of 1.61% and -4.20%, respectively, during the same period.

Source: Investing.com

Ahead of the upcoming RBI policy announcement, Bank Nifty has formed a bullish reversal double-bottom pattern on the daily chart, accompanied by a bullish divergence on the 14-period RSI. Additionally, the price has broken out of a falling trendline, indicating growing strength. If Bank Nifty holds above the 49,700 level, it could trigger a sharp short-covering rally, potentially pushing prices towards the 51,000–51,500 range by the February monthly expiry.

Also Read Three midcap stocks to avoid in this reversal market Here are 10 stocks to watch out for February 06 Two PSU stocks set for Bullish Reversal ICICI Bank: Marching ahead of HDFC Bank?

ALSO READThis financial services behemoth still holds potential for valuation rerating

Given this backdrop, Kotak Bank and ICICI Bank display strong technical setups, positioning them as attractive investment opportunities.

1. Kotak Bank:

While Kotak Bank has been one of the most underperforming stocks among private banks in CY 2024, delivering a modest return of 0.35%, current technical indicators point towards a potential breakout.

Key Technical Insights:

  • Ascending Triangle Formation: A bullish continuation pattern that highlights the strength of the prevailing trend, suggesting an impending upward move.
  • Volume Surge: A noticeable increase in trading volume alongside price movement confirms the breakout’s validity and indicates potential for further upside.
  • RSI in Bullish Zone: The 14-period RSI remains bullish territory, reinforcing the stock’s upward momentum and signalling buying strength.

Source: Investing.com

Outlook:

Kotak Bank broke out from its consolidation/ascending triangle pattern at the end of January 2025, retesting the critical resistance level of ₹1,900 for the third time. The stock failed to sustain the breakout in the previous two attempts, pulling back into the triangle pattern. However, the technical setup suggests renewed strength this time as the stock gears up for another breakout attempt.

  • Third-Time Test at ₹1,900: The repeated testing of this resistance level indicates strong buying interest.

 » Read More

Related Articles

8th Pay Commission: Central govt to merge pay scales for Level 1-6 employees? Here’s what the new proposal says

8th Pay Commission: The National Council of Joint Consultative Machinery (JCM) Staff Side has submitted its recommendations for the Terms of Reference (ToR) for the 8th Central Pay Commission (CPC), advocating significant changes in pay structure, allowances and benefits for government employees. Among the key points of ToR is the proposal for merger of certain

Bharti Airtel Q3 Results: Profit surges 505.24% to Rs 14,781.20 crore, ARPU at Rs 245

Bharti Airtel on Thursday posted a profit of Rs 14,781.20 crore during the third quarter of FY25, reporting a growth of 505.24 per cent in comparison to Rs 2442.20 crore during the corresponding quarter of FY24. The telecom major recorded Q3 revenue from operations at Rs 45,129.30 crore, up 19.08 per cent as against Rs

JB Pharma is riding the CDMO Opportunity. Jefferies reiterates buy…

Jefferies has maintained a Buy on JB Pharma with a revised target price of Rs 2,310. The stock currently trades at Rs 1,714/share implying an 34% upside. This new target price is just a shade lower than the previous target price of Rs 2,340. According to Jefferies, an international brokerage house, the growth drivers are

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Stay Connected

0FansLike
0FollowersFollow
0SubscribersSubscribe
- Advertisement -

Latest Articles

8th Pay Commission: Central govt to merge pay scales for Level 1-6 employees? Here’s what the new proposal says

8th Pay Commission: The National Council of Joint Consultative Machinery (JCM) Staff Side has submitted its recommendations for the Terms of Reference (ToR) for the 8th Central Pay Commission (CPC), advocating significant changes in pay structure, allowances and benefits for government employees. Among the key points of ToR is the proposal for merger of certain

Bharti Airtel Q3 Results: Profit surges 505.24% to Rs 14,781.20 crore, ARPU at Rs 245

Bharti Airtel on Thursday posted a profit of Rs 14,781.20 crore during the third quarter of FY25, reporting a growth of 505.24 per cent in comparison to Rs 2442.20 crore during the corresponding quarter of FY24. The telecom major recorded Q3 revenue from operations at Rs 45,129.30 crore, up 19.08 per cent as against Rs

JB Pharma is riding the CDMO Opportunity. Jefferies reiterates buy…

Jefferies has maintained a Buy on JB Pharma with a revised target price of Rs 2,310. The stock currently trades at Rs 1,714/share implying an 34% upside. This new target price is just a shade lower than the previous target price of Rs 2,340. According to Jefferies, an international brokerage house, the growth drivers are

Two banking stocks to watch ahead of the RBI Policy

By Kiran Jani Bank Nifty reached its all-time high of 54,467 in September 2024. Following this peak, the index experienced a correction, dipping to 47,844 in January 2025—a decline of 7.29%. Despite this pullback, Kotak Bank and ICICI Bank showed relative resilience, delivering returns of 1.61% and -4.20%, respectively, during the same period. Source: Investing.com

New Tax Regime: These deductions, exemptions still available for you

The Indian government introduced a new tax regime in 2020, offering lower tax rates while removing several exemptions and deductions available under the old system. Initially optional, this regime became the default in 2023, requiring taxpayers to opt out if they wished to continue under the old structure. Despite the removal of many benefits, certain